| Albert J Sinusas, MD | |
|
111 Goose Ln, Yale-new Haven Shoreline Medical, Suite 2400, Guilford, CT 06437-5101 | |
| (203) 458-2097 | |
| (203) 458-1592 |
| Full Name | Albert J Sinusas |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 41 Years |
| Location | 111 Goose Ln, Guilford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780665067 | NPI | - | NPPES |
| 001305540 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 030554 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yale University | 9436061736 | 2241 |
News Archive
Doctors in the BMJ have expressed concern over the apparent increase in preterm births. The concerns are based on research showing that preterm deliveries increased by 22% from 1995 to 2004. Even among low risk women aged 20-40, there was a 51% increase in early delivery.
About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.
Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.
› Verified 9 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Doctors in the BMJ have expressed concern over the apparent increase in preterm births. The concerns are based on research showing that preterm deliveries increased by 22% from 1995 to 2004. Even among low risk women aged 20-40, there was a 51% increase in early delivery.
About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.
Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Albert J Sinusas, MD 111 Goose Ln, Yale-new Haven Shoreline Medical, Suite 2400, Guilford, CT 06437-5101 Ph: (203) 458-2097 | Albert J Sinusas, MD 111 Goose Ln, Yale-new Haven Shoreline Medical, Suite 2400, Guilford, CT 06437-5101 Ph: (203) 458-2097 |
News Archive
Doctors in the BMJ have expressed concern over the apparent increase in preterm births. The concerns are based on research showing that preterm deliveries increased by 22% from 1995 to 2004. Even among low risk women aged 20-40, there was a 51% increase in early delivery.
About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
US Oncology, Inc., the nation's premier oncology services company supporting the nation's largest network including more than 1,300 oncologists and more than 10,000 clinicians and cancer experts to advance cancer care in America, was honored on Feb. 6, by Texas Governor Rick Perry at the Texas vs. the Nation All-Star Football Challenge in El Paso, Texas. US Oncology was honored as an inaugural inductee to the Governor's Business Hall of Fame along with Baker Hughes, Bell Helicopter, and Texas Instruments.
Accelerate Brain Cancer Cure and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.
› Verified 9 days ago
Dr. Robert Aaron Levine, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 137 Winthrop Rd, Guilford, CT 06437 Phone: 203-671-0840 | |
Jude F Clancy, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Goose Ln, Yale New Haven Shoreline Medical Center Ste 2400, Guilford, CT 06437 Phone: 203-458-2097 Fax: 203-458-1592 | |
Charles E. Glass, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 96a Broad St, Guilford, CT 06437 Phone: 203-453-3621 Fax: 203-453-4501 | |
Mary J Scheimann, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5 Durham Rd, Bdg 3, C-1, Guilford, CT 06437 Phone: 203-453-4444 Fax: 203-458-9477 | |
Dr. Harold F Stepanek, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 741 Boston Post Rd, Suite 304, Guilford, CT 06437 Phone: 203-671-3561 Fax: 203-453-4594 | |
Donna R Criscenzo, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 199 Goose Lane, Guilford, CT 06437 Phone: 203-458-2888 Fax: 203-458-2889 | |
Fraser Lawrence, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5 Durham Road, Building 3, Guilford, CT 06437 Phone: 203-453-4444 |